UNICREDIT BANK/CALL/ELI LILLY & CO/700/0.1/18.06.25 | Real-time BOERSE MUENCHEN 09:40:26 2024-07-05 am EDT | ||
| 23.65 EUR | +1.37% |
|
| Current month | -5.32% | ||
| 1 month | +25.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 23.65 | +1.37% |
| 24-07-04 | 23.33 | +1.08% |
| 24-07-03 | 23.08 | -4.67% |
| 24-07-02 | 24.21 | -2.50% |
| 24-07-01 | 24.83 | +0.77% |
Real-time BOERSE MUENCHEN
Last update July 05, 2024 at 09:40 am EDT
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HC7N7F |
| ISIN | DE000HC7N7F7 |
| Date issued | 2023-06-23 |
| Strike | 700 $ |
| Maturity | 2025-06-18 (348 Days) |
| Parity | 10 : 1 |
| Emission price | 2.07 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 24.89 € |
|---|---|
| Lowest since issue | 1.34 € |
| Delta | 0.86x |
| Omega | 3.008 |
| Premium | 5.83x |
| Gearing | 3.48x |
| Moneyness | 1.296 |
| Difference Strike | -208.7 $ |
| Difference Strike % | -29.81% |
| Spread | 0.2 € |
| Spread % | 0.83% |
| Theoretical value | 24.06 |
| Implied Volatility | 32.78 % |
| Total Loss Probability | 21.26 % |
| Intrinsic value | 19.17 |
| Present value | 4.887 |
| Break even | 960.43 € |
| Theta | -0.1x |
| Vega | 0.17x |
| Rho | 0.46x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
898.1
USD
Average target price
870.3
USD
Spread / Average Target
-3.10%
- Stock Market
- Warrants
- Warrant
